Skip to main content

Table 4 Risk of occurrence of cardiac arrest among patients to whom the donor management checklist was applied according to the meeting of treatment goals

From: Positive impact of a clinical goal-directed protocol on reducing cardiac arrests during potential brain-dead donor maintenance

Goal met (population analyzed) Total, n = 382 Cardiac arrests, n = 97 (25.4 %) OR (95 % CI) p value
Duration of protocol 12–24 h, n (%) (all)
 Yes 101 (26.4) 19 (18.1) 0.60 (0.34; 1.06) 0.07
 No 281 (73.6) 78 (27.7)   
Temperature > 35 ° C, n (%) (all)
 Yes 283 (74.1) 60 (21.2) 0.48 (0.27; 0.74) 0.001
 No 99 (25.9) 37 (37.3)   
MAP > 65 mmHg, n (%) (all)
 Yes 285 (74.6) 60 (21.1) 0.43 (0.26; 0.71) <0.001
 No 97 (25.4) 37 (38.1)   
Diuresis from 1 to 4 ml/kg/h, n (%) (all)
 Yes 210 (54.9) 49 (23.3) 0.78 (0.49; 1.24) 0.30
 No 172 (45.1) 48 (27.9)   
Corticosteroids, n (%) (all)
 Yes 263 (68.8) 56 (21.3) 0.51 (0.32; 0.83) 0.006
 No 119 (31.2) 41 (34.4)   
Vasopressin, n (%) (vasoconstrictor use, n = 236)
 Yes 41(17.4) 5 (12.2) 0.37 (0.13; 0.99) 0.042
 No 195 (82.6) 53 (27.1)   
Mechanical ventilation, n (%) (all)
 Yes 256 (67.1) 61 (23.8) 0.78 (0.48; 1.27) 0.32
 No 126 (32.9) 36 (28.6)   
Sodium < 150 mEq/L, n (%) (all)
 Yes 142 (37.2) 36 (25.4) 0.99 (0.61; 1.60) 0.99
 No 240 (62.8) 61 (25.5)   
Blood glucose < 180 mg/dl, n (%) (all)
 Yes 151 (39.5) 39 (25.8) 1.03 (0.64; 1.66) 0.87
 No 231 (60.5) 58 (25.1)   
  1. OR odds ratio, CI confidence interval, MAP mean arterial pressure